Evidence for an epidermal cytokine network

Journal of Investigative Dermatology

Volumn 95, Issue 6 SUPPL., 1990, Pages

  Luger, Thomas A ^a,b   Schwarz, Thomas ^b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c City of Vienna Hospital Lainz   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; EPIDERMIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PSORIASIS;

COLONY-STIMULATING FACTORS; CYTOKINES; EPIDERMIS; GROWTH SUBSTANCES; HUMAN; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; SKIN DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPRESSOR FACTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR;

EID: 0025605056     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12874944     Document Type: Article

References (54)

1. W.E. Paul Lymphokine nomenclature Immunol Today 9 1988 366 367
2. A.R. Green Peptide regulatory factors: multifunctional mediators of cellular growth and differentiation Lancet 1 1989 705 707
3. T.A. Luger T. Schwarz Epidermal cytokines J. Bos Skin Immune System 1990 CRC Press Boca Raton 257 292
4. T. Kupper The role of epidermal cytokines JJ. Oppenheim E. Shevach Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation 1989 Oxford University Press 225 305
5. J.J. Oppenheim E.J. Kovacs K. Matsushima S.K. Durum There is more than one interleukin 1 Immunol Today 7 1986 45 49
6. T.A. Luger B.M. Stadler S.I. Katz J.J. Oppenheim Epidermal cell (keratinocyte) derived thymocyte activating factor (ETAF) J Immunol 147 1981 1493 1497
7. D.N. Sauder C. Carter S.I. Katz J.J. Oppenheim Epidermal cell production of thymocyte activating factor (ETAF) J Invest Dermatol 79 1982 34 37
8. C.A. Dinarello Interleukin 1 and its biologically related cytokines Adv Immunol 44 1989 153 205
9. L.C. Gahring A. Buckley R.A. Daynes Presence of epidermal derived thymocyte activating factor IL 1 in normal and human stratum corneum J Clin Invest 76 1985 1585 1589
10. C. Hauser J.H. Saurat A. Schmitt F. Jannin J.M. Dayer Interleukin 1 is present in normal human epidermis J Immunol 136 1986 3317 3321
11. J. Pawelek N. Birchall T. Kupper Interleukin 1 exhibits dual regulation of the MSH receptor system in cloudman 591 melanoma cells (abstr) Clin Res 36 1988 682A
12. T. Schwarz T.A. Luger Effect of UV irradiation on epidermal cell cytokine production J Photochem Photobiol B4 1989 1 13
13. A. Köck E. Schauer T. Schwarz T.A. Luger MSHα and ACTH production by human keratinocytes: a link between the neuronal and the immune system (abstr) J Invest Dermatol 95 1990 543A
14. H. Besedovsky A. Rey E. Sorkin C.A. Dinarello Immunoregulatory feedback between interleukin 1 and glucocorticoid hormones Science 233 1986 652 654
15. G.G. Wong S.C. Clark Multiple actions of interleukin 6 within a cytokine network Immunol Today 9 1988 137 139
16. U. Santhanam S.B. Tatter D.C. Helfgott A. Ray L.T. May P.B. Sehgal Structure genetics and function of human “β2-interferon/B-cell stimulatory factor-2/hepatocyte stimulating factor” (interleukin 6) MC. Powanda Oppenheim. JJ Kluger. MJ CA. Dinarello Monokines and Other Non-Lymphocytic Cytokines 1987 Alan R Liss New York 29 34
17. J. VanDamme Biochemical and biological properties of human HPGF/IL 6 Ann NY Acad Sci 557 1989 102 110
18. R. Kirnbauer A. Köck T. Schwarz A. Urbanski J. Krutmann W. Borth J.C. Ansel T.A. Luger Interferon β2, B-cell differentiation factor, hybridoma growth factor (interleukin 6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines J Immunol 142 1989 1922 1928
19. K. Yamasaki T. Taga T. Matsuda S. Suematsu T. Hirano T. Kishimoto Interleukin 6 and its receptor D. Fradelizi J. Bertoglio Lymphokine receptor interactions 1989 INSERM 143 150
20. A. Cerami B. Beutler The role of cachectin/TNF in endotoxic shock and cachexia Immunol Today 9 1988 28 34
21. D. Pennica M.R. Shiaby M.B. Palladino Jr. Tumor necrosis factors alpha and beta S. Gillis Recombinant Lymphokines and Skin Receptors 1987 Marcel Dekker New York 301 317
22. A.Köck, T.Schwarz, R.Kirnbauer, A.Urbanski, P.Perry, J.C. Ansel, T.A.Luger: Human keratinocytes are a source for tumor necrosis factor alpha. Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med
23. J. Westwick S.W. Li R.D. Camp Novel neutrophil stimulating peptides Immunol Today 10 1989 146 149
24. K. Matsushima J.J. Oppenheim Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF Cytokine 1 1989 2 13
25. J.M. Schröder U. Mrowietz E. Christophers Purification and partial biological characterization of a human lymphocyte derived peptide with potent neutrophil stimulation activity J Immunol 140 1988 3524 3529
26. P. Peveri A. Waltz B. Dewald M. Baggiolini A novel neutrophil activating factor produced by human mononuclear phagocytes J Exp Med 167 1988 1547 1553
27. J. VanDamme J. VanBeeumen G. Opdenakker A. Billiau A novel NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity J Exp Med 167 1988 1364 1369
28. J.M. Schröder E. Christophers Identification of a novel family of highly potent neutrophil chemotactic peptides in psoriatic scales J Invest Dermatol 91 1988 395 399
29. G.G. Larsen A.O. Anderson E. Appella J.J. Oppenheim K. Matsushima The neutrophil activating protein (NAP-1) is also chemotactic for T-lymphocytes Science 243 1989 1644 1648
30. K. Matsushima C.G. Larsen G.C. DuBois J.J. Oppenheim Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line J Exp Med 169 1989 1485 1489
31. S.C. Clark R. Kamen The human hematopoietic colony stimulating factors Science 236 1987 1229 1234
32. D. Metcalf Haemopoietic growth factors 1 Lancet 1 1989 825 827
33. C.A. Sieff Hematopoietic growth factors J Clin Invest 79 1987 1549 1554
34. T.A. Luger A. Köck R. Kirnbauer T. Schwarz J.C. Ansel Keratinocyte derived interleukin 3 Ann NY Acad Sci 548 1989 253 261
35. N.A. Nicola Why do hemopoietic growth factor receptors interact with each other? Immunol Today 8 1987 134 139
36. GJ. Todaro Oncogenes and growth factors CE. Orfanos R. Stadler H. Gollnick 1989 Springer-Verlag Berlin 11 25
37. M.D. Waterfield Epidermal growth factor and related molecules Lancet 1 1989 1243 1246
38. J. Massague The TGFβ family of growth and differentiation factors Cell 49 1987 437 442
39. A.B. Gottlieb G.K. Chang D.N. Posnett B. Fanelli J.P. Tam Detection of transforming growth factor-α in normal, malignant, and hyperproliferative human keratinocytes J Exp Med 167 1988 670 676
40. G. Fisher J. Elder J. Voorhees J. Kawalki C. Petersen R. Derynck L. Ellingsworth Transforming growth factor beta mRNA is expressed in normal and psoriatic epidermis and has similar biological effects on normal and psoriatic lesions cultured keratinocytes (abstr) Clin Res 36 1988 645A
41. R. Ross Platelet-derived growth factor Lancet 12 1989 1179 1182
42. D. Damm G. Shipley C. Hart J. Ansel The expression and modulation of PDGF in normal human keratinocytes (abstr) Cytokine 1 1989 74A
43. K.A. Thomas Fibroblast growth factors Faseb J 1 1987 434 439
44. R. Halaban B.S. Kwon S. Gosh A. Baird bFGF acts as an oncogene in human melanomas (abstr) Clin Res 36 1988 652A
45. T. Schwarz A. Urbanska F. Gschnait T.A. Luger Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine J Invest Dermatol 87 1986 289 291
46. T. Schwarz A. Urbanska F. Gschnait T.A. Luger UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity J Immunol 138 1987 1457 1463
47. S.P. Eisenberg R.J. Evans W.P. Arend E. Vanderbar M.T. Brewer C.H. Hannum R.C. Thompson Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist Nature 343 1990 341 346
48. M.W.N. Nijsten E.R. DeGroot H.J. TenDuis H.J. Klasen C.E. Hack L.A. Aarden Serum levels of interleukin 6 and acute phase responses (letter) Lancet 2 1987 921
49. D.C. Helfgott S.B. Tatter U. Santhanam R.H. Clarick N. Bhardway L.T. May P.B. Sehgal Interferon-β2/interleukin 6 in plasma and body fluids during acute bacterial infection J Immunol 142 1989 948 953
50. P. Neuner A. Kapp R. Kirnbauer A. Urbanski T. Schwarz W. Borth T.A. Luger Monocytes derived from patients with psoriasis synthesize and release increased levels of interleukin 6 (abstr) J Invest Dermatol 92 1989 490A
51. R.M. Grossman J. Krueger D. Yourish A. Granelli-Piperno D.P. Murphy L.T. May T.S. Kupper P.B. Sehgal A.B. Gottlieb Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes Proc Natl Acad Sci USA 86 1989 6367 6371
52. C. Heufler F. Koch G. Schuler Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells J Exp Med 167 1988 700 705
53. F. Koch C. Heufler E. Kämpgen D. Schneeweis G. Böck G. Schuler Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor without inducing their functional maturation J Exp Med 171 1990 159 171
54. M.L. Dustin D.E. Staunton T.A. Springer Supergene families meet in the immune system Immunol Today 9 1988 213 215